2. 您的位置
3. 首页
4. 会议论文
5. Effects of combination therapy of Tamoxifen,L-carnitine and daily PDE5 inhibitors in the Peyronie�

Effects of combination therapy of Tamoxifen,L-carnitine and daily PDE5 inhibitors in the Peyronie�

来源 :泌尿生殖肿瘤华夏医学论坛2016暨长城国际泌尿男科转化医学论坛2016 | 被引量 : 0次 | 上传用户：ankeng

【摘 要】

：

Objective: This study was designed to evaluate the efficacy of combination therapy of Tamoxifen,L-carnitine and daily PDE5 inhibitors and to compare with Potassium para-aminobenzoate (Potaba) monother

【作 者】

：

Jae Il Kang Tae Yong Park Hyeong Guk Jeong Jong Jin Park Ji Yun Chae Jong Wook Kim Mi Mi Oh Hong Seok Park Je Jong Kim Du Geon Moon 

【机 构】

：

Department of Urology, Korea University College of Medicine, Korea

【出 处】

：

泌尿生殖肿瘤华夏医学论坛2016暨长城国际泌尿男科转化医学论坛2016

【发表日期】

：

2016年8期

【关键词】

：

Peyronie's disease tamoxifen PDE5 inhibitors 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: This study was designed to evaluate the efficacy of combination therapy of Tamoxifen,L-carnitine and daily PDE5 inhibitors and to compare with Potassium para-aminobenzoate (Potaba) monotherapy in the medical treatment of Peyronies disease.

其他文献

Correlation between androgen receptor CAG repeat length polymorphism and metabolic syndrome, late on

Objective: It is generally assumed that there is a negative linear association between androgen receptor (AR) sensitivity and the CAG repeat length.However,correlation between CAG repeat length and cl

会议

Androgen receptor (AR)polymorphismmetabolic syndrome

Clinical analysis of small cell carcinoma of the bladder: 9 cases report and literature review

Objective: To present our experience with nine patients with small cell carcinoma of the bladder (SCCB) who were treated with different modalities and review the literature for patients with SCCB who

会议

Bladder cancersmall cell carcinomaneuroendocrine carcinomachemotherapy

Simultaneous bilateral retroperitoneal laparoscopic nephron sparing surgery: case report and evaluat

Objective: Blateral renal cell carcinoma (RCC) is an extremely rare renal tumor,even more infrequently with two different types of pathology.Methods: We present a case of bilateral RCC with simultaneo

会议

Retroperitoneal laparoscopicnephron-sparing surgeryrenal cell carcinoma (RCC)

Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT

Objective: To compare the prognosis of locally advanced upper tract urothelial carcinoma (UTUC) and bladder cancer (BC) in patients treated with radical surgeries.Methods: A retrospective analysis of

会议

Bladder cancer (BC)upper tract urothelial carcinoma (UTUC)radical cystectomyr

Diagnostic ureteroscopy for upper tract urothelial carcinoma is independently associated with intrav

Objective: To determine the effect of diagnostic ureteroscopy on intravesical recurrence in patients with upper tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU).Methods: We con

会议

Upper tract urothelial carcinomaradical nephroureterectomy (RNU)intravesical r

Treatment strategies for upper tract urothelial carcinoma of the solitary functioning kidney: clinic

Objective: To explore the treatment strategies for patients with upper tract urothelial carcinoma of the solitary functioning kidney.Methods: Retrospective analysis of 61 cases who underwent operation

会议

UTUCsolitary functioning kidneynephron-sparing surgery (NSS)radical nephroure

Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histologi

Objective: To investigate the efficacy of initial biopsy or transurethral resection of bladder tumor for detecting histological variants on radical cystectomy and to assess the prognostic significance

会议

Urothelial carcinomavariant histologic differentiationcystectomypathologypro

The splicing factor SRSF1 expression in human bladder carcinoma cells

Objective: SRSF1 is a splicing factor often times described as an oncoprotein.In the present work,we examined the expression of SRSF1 in human bladder carcinoma cells and detected the change of SRSF1

会议

SRSF1bladder carcinomasplicing factorpirarubicin

High novel oncogene with kinase-domain (NOK) gene expression is associated with the progression of r

Objective: To study the expression levels of the NOK (novel oncogene with kinase-domain) gene in renal cell carcinoma (RCC) and its association with the progression of this cancer.Methods: In this stu

会议

Renal cell carcinoma (RCC)oncogenenovel oncogene with kinase-domain (NOK)prog

The effect of Seoritae extract in men with mild-to-moderate lower urinary tract symptoms suggestive

Objective: We evaluated the effects of Seoritae extract (SE) on mild-to-moderate lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).Methods: Seventy-six subjects with

会议

Lower urinary tract symptoms (LUTS)Seoritae extract (SE)benign prostatc hyperp